The Marie Skłodowska-Curie Actions Innovative Training Network "SINERGIA" looks for 15 motivated early-stage researcher (ESR)
All positions give the opportunity of the enrolment in a PhD program. The contracts will be for 36 months with a competitive salary (the precise amount depends on the Country and family status).
The SINERGIA Network is devoted to the development of novel in vitro preclinical models, based on 4 cutting-edge technologies: bioprintin, organs-on-chip, 3D cell culture and induced pluripotent stem cells. SINERGIA is funded under Marie Sklodowska-Curie actions (H2020-MSCA-ITN-2019, grant agreement number: 860715).
The Network comprises 10 beneficiaries and 4 partner organisations from both the academic and industrial sectors from 6 countries (Italy, Switzerland, The Netherlands, Czech Republic, Germany and United Kingdom).
The SINERGIA project provides research and training opportunities for early-stage researchers in the field the emerging technologies in drug development and precision medicine. Specifically, SINERGIA aims at improving the dialogue among the main stakeholders in the drug discovery field, and at developing advanced models of human physiology and diseases, to be ultimately introduced in the preclinical stages of the drug discovery pipeline.
Further details:
15 PhD positions at European Training Network SINERGIA